South San Francisco, CA, United States of America

Emily J Hanan

This inventor holds 17 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 17 EPO patents. Top assignee: Genentech, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emily J Hanan. Retrieved from https://idiyas.com/inventor/emily-j-hanan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 20)

% Patents Active = 64.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 17 (Patent Applications = 21)

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 93(Granted Patents)

Location History:

Redwood City, CA (US) (2013 - 2023)
South San Francisco, CA (US) (2018 - 2023)

Company Filing History:

17 out of 3,298

Genentech, Inc.

patents

Years Active: 2013-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358951 - Cyclic peptide antibiotics (2025-07-15),

2. 11760753 - Benzoxazepin oxazolidinone compounds and methods of use (2023-09-19),

3. 11649241 - Pyrazolochlorophenyl compounds, compositions and methods of use thereof (2023-05-16),

4. 11279735 - Cyclic peptide antibiotics (2022-03-22),

5. 10851091 - Benzoxazepin oxazolidinone compounds and methods of use (2020-12-01),

6. 10435414 - Tricyclic PI3K inhibitor compounds and methods of use (2019-10-08),

7. 10112932 - Benzoxazepin oxazolidinone compounds and methods of use (2018-10-30),

8. 10065970 - Tricyclic PI3K inhibitor compounds and methods of use (2018-09-04),

9. 9951064 - Azaindazole compounds as inhibitors of T790M containing EGFR mutants (2018-04-24),

10. 9890152 - Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants (2018-02-13),

11. 9650393 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-16),

12. 9643980 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-09),

13. 9206175 - Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof (2015-12-08),

14. 8999998 - Pyrazolopyrimidine JAK inhibitor compounds and methods (2015-04-07),

15. 8637526 - Pyrazolopyrimidine JAK inhibitor compounds and methods (2014-01-28),

Title: The Innovative Journey of Emily J Hanan

Introduction: Emily J Hanan, a pioneering inventor based in South San Francisco, CA, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Emily J Hanan's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a background in engineering and a passion for innovation, Emily J Hanan has a successful track record of developing patented technologies that have improved the lives of many. Her career highlights include receiving multiple awards for her innovative solutions and being recognized as a thought leader in the tech community.

Collaborations: Throughout her career, Emily J Hanan has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and industries has led to the creation of cutting-edge technologies that have had a lasting impact.

Conclusion: Emily J Hanan's dedication to pushing the boundaries of technology and her commitment to creating solutions that address real-world challenges make her a true trailblazer in the world of innovation. Her passion for inventing, coupled with her drive to make a difference, continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.